| |
 |
|
|
|
|
|
Poster: 124
Visits: 10
Title: The use of turoctocog alfa for the prevention and treatment of bleeds in patients with hemophilia A: efficacy data from European countries included in the guardian2 clinical trial
Authors: Bridget Brand ,
Centre: University Hospital Zurich, Zurich, Switzerland
|
|
You must be registered to reply or comment.
|
|
THE USE OF TUROCTOCOG ALFA FOR THE PREVENTION AND TREATMENT OF BLEEDS IN PATIENTS WITH HEMOPHILIA A: EFFICACY DATA FROM EUROPEAN COUNTRIES INCLUDED IN THE GUARDIAN2 CLINICAL TRIAL
|
|
| You must be registered to reply or comment. |
|
|
|
|
|
|
| Most viewed poster for this congress |
|
|
Poster: 13
Visits: 590
Title: Algorithmic evidence-based phenotype screening and collaborative approach to attacking symptoms of nonadherence in patients with bleeding disorders
Authors: Jay Bryant-Wimp , Jay Bryant-Wimp, RPh
Centre: Integrite Solutions
|
|
|
|
|
|
|
| Poster most viewed in this topic |
|
|
Poster: 97
Visits: 120
Title: Safety and efficacy of turoctocog alfa for prophylaxis and treatment of bleeding episodes in patients with severe hemophilia A: results from the guardian2 trial
Authors: Elena Santagostino ,
Centre: Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Maggiore Hospital Policlinico, Milan, Italy
|
|
|
|
